November 30, 2022
Dear Advocate,
We are excited to release a new edition of our
PxPulse podcast
New Products are Needed and a New Paradigm is Essential: A new era in prevention?
Tomorrow will be the 34th anniversary of World AIDS Day. It comes as countries around the world are approving
diverse new options for PrEP, and the
uptake of oral PrEP is reaching new heights. For the first time, the HIV response can offer the choice of multiple biomedical options—some long acting, some user controlled, some daily—that protect against HIV. At this critical juncture, global conversations are underway that could
leverage this new era of choice and fundamentally reimagine how the world delivers prevention, not just for HIV but as a new paradigm for global health equity and impact. At AVAC, we have been talking about the unprecedented opportunity to dramatically reduce the number of new infections, and to lay the foundation to overcome systemic inequities in global health.
This
podcast explores these questions in depth and features
PEPFAR Ambassador Dr. John Nkengasong;
Kenneth Mwehonge, Executive Director of
HEPS-Uganda and
former AVAC Advocacy Fellow; and Lilian Benjamin Mwakyosi, the Executive Director of
DARE in Tanzania and
former AVAC Advocacy Fellow. Listen to the
full podcast here, and listen to this
snippet of Amb. Nkengasong in his appeal for an aggressive strategy to scale up combination prevention, including injectable cabotegravir for PrEP (
🎧).
As we reflect on so many 2022 milestones—the
7th replenishment of the Global Fund, new leadership and a
new strategic direction at PEPFAR, the launch of the
Pandemic Fund, the launch of the
Global HIV Prevention Coalition 2025 Roadmap, the introduction of the
dapivirine vaginal ring and
injectable cabotegravir for PrEP—we call on our global community to join us in marking this a turning point toward reaching equity and impact in HIV prevention.
This World AIDS Day:
